Request for Covid-19 Impact Assessment of this Report
The United States Glutamate Receptor Ionotropic NMDA 2B market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Glutamate Receptor Ionotropic NMDA 2B market, reaching US$ million by the year 2028. As for the Europe Glutamate Receptor Ionotropic NMDA 2B landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Glutamate Receptor Ionotropic NMDA 2B players cover BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Glutamate Receptor Ionotropic NMDA 2B market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Glutamate Receptor Ionotropic NMDA 2B by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Glutamate Receptor Ionotropic NMDA 2B by Country/Region, 2017, 2022 & 2028
2.2 Glutamate Receptor Ionotropic NMDA 2B Segment by Type
2.2.1 JNJ-0808
2.2.2 Neu-2000
2.2.3 NP-10679
2.2.4 NP-11948
2.2.5 Radiprodil
2.2.6 Others
2.3 Glutamate Receptor Ionotropic NMDA 2B Sales by Type
2.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)
2.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue and Market Share by Type (2017-2022)
2.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Type (2017-2022)
2.4 Glutamate Receptor Ionotropic NMDA 2B Segment by Application
2.4.1 Acute Ischemic Stroke
2.4.2 Autism
2.4.3 Brain Ischemia
2.4.4 Burns
2.4.5 Others
2.5 Glutamate Receptor Ionotropic NMDA 2B Sales by Application
2.5.1 Global Glutamate Receptor Ionotropic NMDA 2B Sale Market Share by Application (2017-2022)
2.5.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue and Market Share by Application (2017-2022)
2.5.3 Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Application (2017-2022)
3 Global Glutamate Receptor Ionotropic NMDA 2B by Company
3.1 Global Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Company
3.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Annual Sales by Company (2020-2022)
3.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Company (2020-2022)
3.2 Global Glutamate Receptor Ionotropic NMDA 2B Annual Revenue by Company (2020-2022)
3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Company (2020-2022)
3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Company (2020-2022)
3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Company
3.4 Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Location Distribution
3.4.2 Players Glutamate Receptor Ionotropic NMDA 2B Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Glutamate Receptor Ionotropic NMDA 2B by Geographic Region
4.1 World Historic Glutamate Receptor Ionotropic NMDA 2B Market Size by Geographic Region (2017-2022)
4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Annual Revenue by Geographic Region
4.2 World Historic Glutamate Receptor Ionotropic NMDA 2B Market Size by Country/Region (2017-2022)
4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Annual Sales by Country/Region (2017-2022)
4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Annual Revenue by Country/Region
4.3 Americas Glutamate Receptor Ionotropic NMDA 2B Sales Growth
4.4 APAC Glutamate Receptor Ionotropic NMDA 2B Sales Growth
4.5 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Growth
4.6 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Growth
5 Americas
5.1 Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Country
5.1.1 Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022)
5.1.2 Americas Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022)
5.2 Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Type
5.3 Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Region
6.1.1 APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2017-2022)
6.1.2 APAC Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2017-2022)
6.2 APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Type
6.3 APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Glutamate Receptor Ionotropic NMDA 2B by Country
7.1.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022)
7.1.2 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022)
7.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type
7.3 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B by Country
8.1.1 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022)
8.1.2 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022)
8.2 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type
8.3 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B
10.3 Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B
10.4 Industry Chain Structure of Glutamate Receptor Ionotropic NMDA 2B
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glutamate Receptor Ionotropic NMDA 2B Distributors
11.3 Glutamate Receptor Ionotropic NMDA 2B Customer
12 World Forecast Review for Glutamate Receptor Ionotropic NMDA 2B by Geographic Region
12.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Region
12.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Forecast by Region (2023-2028)
12.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glutamate Receptor Ionotropic NMDA 2B Forecast by Type
12.7 Global Glutamate Receptor Ionotropic NMDA 2B Forecast by Application
13 Key Players Analysis
13.1 BioCrea GmbH
13.1.1 BioCrea GmbH Company Information
13.1.2 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Offered
13.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 BioCrea GmbH Main Business Overview
13.1.5 BioCrea GmbH Latest Developments
13.2 Bristol-Myers Squibb Company
13.2.1 Bristol-Myers Squibb Company Company Information
13.2.2 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Offered
13.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bristol-Myers Squibb Company Main Business Overview
13.2.5 Bristol-Myers Squibb Company Latest Developments
13.3 Cerecor Inc.
13.3.1 Cerecor Inc. Company Information
13.3.2 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offered
13.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cerecor Inc. Main Business Overview
13.3.5 Cerecor Inc. Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Offered
13.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Luc Therapeutics, Inc.
13.5.1 Luc Therapeutics, Inc. Company Information
13.5.2 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offered
13.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Luc Therapeutics, Inc. Main Business Overview
13.5.5 Luc Therapeutics, Inc. Latest Developments
13.6 NeurOp, Inc
13.6.1 NeurOp, Inc Company Information
13.6.2 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Offered
13.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 NeurOp, Inc Main Business Overview
13.6.5 NeurOp, Inc Latest Developments
13.7 Novartis AG
13.7.1 Novartis AG Company Information
13.7.2 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Offered
13.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novartis AG Main Business Overview
13.7.5 Novartis AG Latest Developments
13.8 UCB S.A.
13.8.1 UCB S.A. Company Information
13.8.2 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Offered
13.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 UCB S.A. Main Business Overview
13.8.5 UCB S.A. Latest Developments
14 Research Findings and Conclusion
Table 1. Glutamate Receptor Ionotropic NMDA 2B Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Glutamate Receptor Ionotropic NMDA 2B Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of JNJ-0808
Table 4. Major Players of Neu-2000
Table 5. Major Players of NP-10679
Table 6. Major Players of NP-11948
Table 7. Major Players of Radiprodil
Table 8. Major Players of Others
Table 9. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 10. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)
Table 11. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2017-2022) & ($ million)
Table 12. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2017-2022)
Table 13. Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Type (2017-2022) & (USD/Pcs)
Table 14. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 15. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)
Table 16. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2017-2022)
Table 17. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2017-2022)
Table 18. Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Application (2017-2022) & (USD/Pcs)
Table 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Company (2020-2022) & (K Pcs)
Table 20. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Company (2020-2022)
Table 21. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Company (2020-2022)
Table 23. Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Company (2020-2022) & (USD/Pcs)
Table 24. Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Producing Area Distribution and Sales Area
Table 25. Players Glutamate Receptor Ionotropic NMDA 2B Products Offered
Table 26. Glutamate Receptor Ionotropic NMDA 2B Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Geographic Region (2017-2022) & (K Pcs)
Table 30. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Geographic Region (2017-2022)
Table 31. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Country/Region (2017-2022) & (K Pcs)
Table 34. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country/Region (2017-2022)
Table 35. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022) & (K Pcs)
Table 38. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2017-2022)
Table 39. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2017-2022)
Table 41. Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 42. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)
Table 43. Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 44. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)
Table 45. APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2017-2022) & (K Pcs)
Table 46. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2017-2022)
Table 47. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2017-2022)
Table 49. APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 50. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)
Table 51. APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 52. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)
Table 53. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022) & (K Pcs)
Table 54. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2017-2022)
Table 55. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2017-2022)
Table 57. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)
Table 59. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 60. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)
Table 68. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Glutamate Receptor Ionotropic NMDA 2B
Table 70. Key Market Challenges & Risks of Glutamate Receptor Ionotropic NMDA 2B
Table 71. Key Industry Trends of Glutamate Receptor Ionotropic NMDA 2B
Table 72. Glutamate Receptor Ionotropic NMDA 2B Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Glutamate Receptor Ionotropic NMDA 2B Distributors List
Table 75. Glutamate Receptor Ionotropic NMDA 2B Customer List
Table 76. Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Region (2023-2028) & (K Pcs)
Table 77. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Forecast by Region
Table 78. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Region (2023-2028) & (K Pcs)
Table 83. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Type (2023-2028) & (K Pcs)
Table 89. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Application (2023-2028) & (K Pcs)
Table 93. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share Forecast by Application (2023-2028)
Table 96. BioCrea GmbH Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors
Table 97. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Offered
Table 98. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 99. BioCrea GmbH Main Business
Table 100. BioCrea GmbH Latest Developments
Table 101. Bristol-Myers Squibb Company Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors
Table 102. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Offered
Table 103. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 104. Bristol-Myers Squibb Company Main Business
Table 105. Bristol-Myers Squibb Company Latest Developments
Table 106. Cerecor Inc. Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors
Table 107. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offered
Table 108. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 109. Cerecor Inc. Main Business
Table 110. Cerecor Inc. Latest Developments
Table 111. Johnson & Johnson Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors
Table 112. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Offered
Table 113. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 114. Johnson & Johnson Main Business
Table 115. Johnson & Johnson Latest Developments
Table 116. Luc Therapeutics, Inc. Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors
Table 117. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offered
Table 118. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 119. Luc Therapeutics, Inc. Main Business
Table 120. Luc Therapeutics, Inc. Latest Developments
Table 121. NeurOp, Inc Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors
Table 122. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Offered
Table 123. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 124. NeurOp, Inc Main Business
Table 125. NeurOp, Inc Latest Developments
Table 126. Novartis AG Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors
Table 127. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Offered
Table 128. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 129. Novartis AG Main Business
Table 130. Novartis AG Latest Developments
Table 131. UCB S.A. Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors
Table 132. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Offered
Table 133. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 134. UCB S.A. Main Business
Table 135. UCB S.A. Latest Developments
List of Figures
Figure 1. Picture of Glutamate Receptor Ionotropic NMDA 2B
Figure 2. Glutamate Receptor Ionotropic NMDA 2B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of JNJ-0808
Figure 10. Product Picture of Neu-2000
Figure 11. Product Picture of NP-10679
Figure 12. Product Picture of NP-11948
Figure 13. Product Picture of Radiprodil
Figure 14. Product Picture of Others
Figure 15. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type in 2021
Figure 16. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2017-2022)
Figure 17. Glutamate Receptor Ionotropic NMDA 2B Consumed in Acute Ischemic Stroke
Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Market: Acute Ischemic Stroke (2017-2022) & (K Pcs)
Figure 19. Glutamate Receptor Ionotropic NMDA 2B Consumed in Autism
Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Market: Autism (2017-2022) & (K Pcs)
Figure 21. Glutamate Receptor Ionotropic NMDA 2B Consumed in Brain Ischemia
Figure 22. Global Glutamate Receptor Ionotropic NMDA 2B Market: Brain Ischemia (2017-2022) & (K Pcs)
Figure 23. Glutamate Receptor Ionotropic NMDA 2B Consumed in Burns
Figure 24. Global Glutamate Receptor Ionotropic NMDA 2B Market: Burns (2017-2022) & (K Pcs)
Figure 25. Glutamate Receptor Ionotropic NMDA 2B Consumed in Others
Figure 26. Global Glutamate Receptor Ionotropic NMDA 2B Market: Others (2017-2022) & (K Pcs)
Figure 27. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)
Figure 28. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application in 2021
Figure 29. Glutamate Receptor Ionotropic NMDA 2B Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Company in 2021
Figure 31. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Geographic Region in 2021
Figure 33. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2017-2022)
Figure 34. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country/Region in 2021
Figure 35. Americas Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2022 (K Pcs)
Figure 36. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue 2017-2022 ($ Millions)
Figure 37. APAC Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2022 (K Pcs)
Figure 38. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue 2017-2022 ($ Millions)
Figure 39. Europe Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2022 (K Pcs)
Figure 40. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2022 (K Pcs)
Figure 42. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue 2017-2022 ($ Millions)
Figure 43. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country in 2021
Figure 44. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country in 2021
Figure 45. United States Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region in 2021
Figure 50. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Regions in 2021
Figure 51. China Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country in 2021
Figure 58. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country in 2021
Figure 59. Germany Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country in 2021
Figure 66. Egypt Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B in 2021
Figure 72. Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B
Figure 73. Industry Chain Structure of Glutamate Receptor Ionotropic NMDA 2B
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...